B 376 (Imatinib Mesylate 100 mg)
Pill with imprint B 376 is Brown, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Breckenridge Pharmaceutical, Inc.
Imatinib is used in the treatment of chronic myelogenous leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B 376
Imatinib Mesylate
- Imprint
- B 376
- Strength
- 100 mg
- Color
- Brown
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- Manufacturer
- Stason Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 51991-0376
Related images for "B 376"
More about imatinib
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (41)
- Drug images
- Pricing & coupons
- En español
- Drug class: BCR-ABL tyrosine kinase inhibitors
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.